| TGFβ2-mediated production of hyaluronan is important for the induction of epicardial cell differentiation and invasion. | |
| | |
MedLine Citation:
|
PMID: 20633555 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In the developing heart, the epicardium is a major source of progenitor cells that contribute to the formation of the coronary vessel system. These epicardial progenitors give rise to the different cellular components of the coronary vasculature by undergoing a number of morphological and physiological changes collectively known as epithelial to mesenchymal transformation (EMT). However, the specific signaling mechanisms that regulate epicardial EMT are yet to be delineated. In this study we investigated the role of TGFβ2 and hyaluronan (HA) during epicardial EMT and how signals from these two molecules are integrated during this important process. Here we show that TGFβ2 induces MEKK3 activation, which in turn promotes ERK1/2 and ERK5 phosphorylation. TGFβ2 also increases Has2 expression and subsequent HA production. Nevertheless, inhibition of MEKK3 kinase activity, silencing of ERK5 or pharmacological disruption of ERK1/2 activation significantly abrogates this response. Thus, TGFβ2 promotes Has2 expression and HA production through a MEKK3/ERK1/2/5-dependent cascade. Furthermore, TGFβ2 is able to induce epicardial cell invasion and differentiation but not proliferation. However, inhibition of MEKK3-dependent pathways, degradation of HA by hyaluronidases or blockade of CD44, significantly impairs the biological response to TGFβ2. Taken together, these findings demonstrate that TGFβ2 activation of MEKK3/ERK1/2/5 signaling modulates Has2 expression and HA production leading to the induction of EMT events. This is an important and novel mechanism showing how TGFβ2 and HA signals are integrated to regulate changes in epicardial cell behavior. |
| | |
Authors:
|
Evisabel A Craig; Anita F Austin; Richard R Vaillancourt; Joey V Barnett; Todd D Camenisch |
Related Documents
:
|
17325015 - Mathematical models of specificity in cell signaling. 22442725 - The origin and evolution of g protein-coupled receptor kinases. 19641115 - Ethanol affects transforming growth factor beta1-initiated signals: cross-talking pathw... 21289475 - Differential virulence of candida albicans and c. dubliniensis: a role for tor1 kinase? 19105645 - Neuroprotective effects of glycyrrhizic acid and 18beta-glycyrrhetinic acid in pc12 cel... 3756225 - Involvement of protein kinase c in the phosphorylation of 46 kda proteins which are pho... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2010-07-13 |
Journal Detail:
|
Title: Experimental cell research Volume: 316 ISSN: 1090-2422 ISO Abbreviation: Exp. Cell Res. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-09 Completed Date: 2011-01-26 Revised Date: 2011-11-02 |
Medline Journal Info:
|
Nlm Unique ID: 0373226 Medline TA: Exp Cell Res Country: United States |
Other Details:
|
Languages: eng Pagination: 3397-405 Citation Subset: IM |
Copyright Information:
|
Published by Elsevier Inc. |
Affiliation:
|
Department of Pharmacology and Toxicology, The University of Arizona, Tucson, AZ 85721, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antibodies, Monoclonal / immunology, pharmacology Antigens, CD44 / immunology Cell Line Cell Movement / drug effects, physiology* Epithelial-Mesenchymal Transition / drug effects, physiology* Gene Expression / drug effects, genetics Glucuronosyltransferase / genetics, metabolism Humans Hyaluronic Acid / metabolism* Hyaluronoglucosaminidase / pharmacology MAP Kinase Kinase Kinase 3 / genetics, metabolism Mice Mice, Transgenic Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors, metabolism Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors, metabolism Mitogen-Activated Protein Kinase 7 / genetics, metabolism Pericardium / cytology* Phosphorylation / drug effects RNA, Small Interfering / genetics Signal Transduction / drug effects, physiology Stem Cells / cytology*, drug effects, metabolism Transforming Growth Factor beta2 / pharmacology* Vimentin / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
ES04940/ES/NIEHS NIH HHS; HL077493/HL/NHLBI NIH HHS; HL085708/HL/NHLBI NIH HHS; HL095155/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antigens, CD44; 0/RNA, Small Interfering; 0/TGFB2 protein, human; 0/Transforming Growth Factor beta2; 0/Vimentin; 9004-61-9/Hyaluronic Acid; EC 2.4.1.-/Has2 protein, mouse; EC 2.4.1.17/Glucuronosyltransferase; EC 2.7.11.24/MAPK1 protein, human; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 2.7.11.24/Mitogen-Activated Protein Kinase 3; EC 2.7.11.24/Mitogen-Activated Protein Kinase 7; EC 2.7.11.25/MAP Kinase Kinase Kinase 3; EC 2.7.11.25/Map3k3 protein, mouse; EC 3.2.1.35/Hyaluronoglucosaminidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Regulation of gene expression in vertebrate skeletal muscle.
Next Document: A Cajal body-independent pathway for telomerase trafficking in mice.